Estimated Half-Life of SARS-CoV-2 Anti-Spike Antibodies More Than Double the Half-Life of Anti-nucleocapsid Antibodies in Healthcare Workers. (2021)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/cid/ciab219
PubMed Identifier: 33693643
Publication URI: http://europepmc.org/abstract/MED/33693643
Type: Journal Article/Review
Volume: 73
Parent Publication: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Issue: 12
ISSN: 1058-4838